Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Core EBITDA Growth

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 35.7080.69186.95-48.932.87

What is the latest Core EBITDA Growth ratio of NATCO PHARMA ?

The latest Core EBITDA Growth ratio of NATCO PHARMA is 35.70 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202535.70
Mar202480.69
Mar2023186.95
Mar2022-48.93
Mar20212.87

How is Core EBITDA Growth of NATCO PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 35.7
-55.76
Mar2024 80.69
-56.84
Mar2023 186.95
Positive
Mar2022 -48.93
Negative
Mar2021 2.87 -

Other Financial Ratios of NATCO PHARMA


Compare Core EBITDA Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,737.8 Cr 0.7% 13.8% -32.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,248.0 Cr -0.4% 6.4% 4.2% Stock Analytics
DIVIS LABORATORIES ₹171,344.0 Cr -1.5% -4.9% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,832.0 Cr -0.7% 4.8% 16.6% Stock Analytics
CIPLA ₹121,820.0 Cr -0.5% 1% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹106,877.0 Cr 2.2% 6.6% 5.7% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

0.7%

13.8%

-32.5%

SENSEX

-0.6%

1.4%

7.7%


You may also like the below Video Courses